Pharma Journalist 8916 posts 0 comments

Altimmune, Inc. a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND)…
Read More...

SMi Reports: There will be a workshop on ‘Developing Apps for Connected Drug Delivery Devices- a practical and integrated HF approach SMi is proud to present the Injectable Drug…
Read More...

Harnessing the activation of innate immunity has become the forefront of new cancer immunotherapies. Only this month SQZ Biotech received FDA clearance for an IND on a cell therapy…
Read More...

Boston Immune Technologies and Therapeutics, Inc. (BITT), a privately held developer of novel antagonist antibodies for cancer and other diseases, and BeiGene, Ltd. announced that they…
Read More...

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced they have signed a binding agreement to expand their existing collaboration to include the research and development of new…
Read More...

Iterion Therapeutics, Inc. ("Iterion"), a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, announced that it has raised $17 million USD in a…
Read More...

Johnson & Johnson announced that Janssen-Cilag International N.V., has submitted a conditional Marketing Authorisation Application (cMAA) to the European Medicines Agency (EMA)…
Read More...

In just the last week few weeks there have been clinical updates from Pfizer, Sarepta and Audentes on their programs in muscular disorders. The timely Gene Therapy for Muscular…
Read More...

Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that animal testing has commenced with two…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved the following expanded indication for Entresto (sacubitril/valsartan): to reduce the risk of…
Read More...